2026 Retinal vasculitis indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need, competition and market attractiveness.

2026 Diffuse subretinal fibrosis syndrome indication strategy covering epidemiology, TGF-beta biology, active trials, transactions, unmet need, competition and…

2026 Serpiginous choroiditis indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need, competition and market attractiveness.

2026 Punctate inner choroidopathy indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need, competition and market…

2026 Multifocal choroiditis with panuveitis indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need, competition and…

2026 Acute posterior multifocal placoid pigment epitheliopathy indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need,…

2026 Mucous membrane pemphigoid with ocular involvement indication strategy covering epidemiology, C5 biology, active trials, transactions, unmet need,…

2026 Erythrodermic psoriasis indication strategy covering epidemiology, IL-17 biology, active trials, transactions, unmet need, competition and market…

2026 Acrodermatitis continua of Hallopeau indication strategy covering epidemiology, IL-36R biology, active trials, transactions, unmet need, competition and…

2026 Acute generalized exanthematous pustulosis indication strategy covering epidemiology, IL-36 biology, active trials, transactions, unmet need, competition…

2026 Drug reaction with eosinophilia and systemic symptoms indication strategy covering epidemiology, IL-5 biology, active trials, transactions, unmet need,…

2026 Acute cutaneous graft-versus-host disease indication strategy covering epidemiology, JAK biology, active trials, transactions, unmet need, competition and…